Neurology News

Last year, we wrote about the five top financial mistakes Dr. Bhatia has seen in fellow physicians, especially at the beginning of their careers. We covered this for our Forward Thinking column in Orthopedics Today, a Healio publication.

Treatment-associated frailty appeared associated with neurocognitive declines among a cohort of young-adult cancer survivors, according to study findings from the St. Jude Lifetime Cohort published in Journal of Clinical Oncology.

Unmet need was high among patients with Alzheimer’s disease and related dementias during the COVID-19 pandemic, according to study results presented at the Alzheimer’s Association International Conference.

The online tool Outreach Pro was launched at the Alzheimer’s Association International Conference to raise awareness of clinical trials for Alzheimer’s disease and other dementias, specifically in “traditionally underrepresented communities.”

Four papers offer new insight into long COVID symptoms, duration, onset and prevalence, with one paper documenting more than 200 symptoms of long COVID.

Forgetfulness continued in more than half of older adults studied between 3 to 6 months after COVID-19, while one in four experienced added issues with cognition, including language and executive dysfunction.

Total sugar intake may affect cognitive function over time, with higher amounts potentially increasing risk for Alzheimer’s disease, according to study results presented at the Alzheimer’s Association International Conference.

Among patients who underwent left ventricular arrhythmia ablation with a radiofrequency catheter, direct oral anticoagulants were superior to aspirin in preventing cerebrovascular events, according to the results of the STROKE-VT trial.

Adrenocorticotropic hormone and oral steroids demonstrated superiority compared with non-standard therapy for the initial treatment of infantile spams in a prospective, multicenter observational cohort study published in Neurology.

Physical activity may reduce age-associated risk for all-cause dementia among older adults, according to results of a population-based cohort study presented at the Alzheimer’s Association International Conference.